Results
1
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
1 companies
BioSyent
Market Cap: CA$130.0m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.63
7D
-2.7%
1Y
27.4%